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In the article under evaluation, the authors 
studied the in vitro effect of IL-15 on the dif-
ferentiation of inducible Treg cells [1]. Celiac 
disease is a good example of a case in which 
a breakdown of oral tolerance to dietary glu-
ten leads to the development of gluten-related 
enteropathy, and IL-15 is overexpressed in the 
intestine of patients with celiac disease [2]. By 
using IL-15-stimulated intestinal dendritic cells 
(DCs; from mesenteric lymph nodes [MLNs]), 
the authors demonstrated that the generation 
of Treg cells is impaired compared with non-
stimulated controls, and that this is mediated 
by a direct effect of IL-15 on DCs, but not on 
T cells. These results were confirmed in vivo by 
feeding transgenic mice that overexpress IL-15 
in the intestinal lamina propria and MLN with 
ovalbumin (OVA), a known model antigen used 
to study oral tolerance. OVA-fed transgenic mice 
demonstrated a significantly decreased number 
of OVA-specific Treg cells in MLN, as compared 
with the OVA-fed wild-type mice. Moreover, 
the addition of retinoic acid (RA) had an even 
greater negative effect on the generation of Treg 
cells in the OVA-fed transgenic mouse model.
In order to further clarify the mechanisms 
underlying the effects of IL-15 and RA, the 
authors used IL-15-stimulated splenic DCs 
(which unlike MLN DCs, do not produce 
RA), and found that IL-15 and RA cooperate 
in the DC-mediated production of the pro-
inflammatory cytokines IL-12p70 and IL-23. 
The negative effect of IL-15 on Treg cell differ-
entiation occurs in parallel with the induction 
of a T helper 1 (Th1) response (which is known 
to depend on IL-12), as observed by in vitro and 
in vivo experiments. Moreover, RA cooperates 
with IL-15 in promoting the development of 
effector T cells, and, together with the presence 
of either IL-12p70 or IL-6, will lead to the polar-
ization towards a Th1 or Th17-type response, 
respectively. The proinflammatory effects of 
IL-15 (increased DC-mediated production of 
IL-12p70 and IL-23, and impaired generation 
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The physiological immune response in the intestine against dietary proteins and commensal 
flora is characterized by regulatory mechanisms (tolerance) that prevent harmful consequences. 
Intestinal dendritic cells (DCs) have a central role in the development of immunosuppressive 
regulatory T cells owing to their ability to produce TGF-b and retinoic acid (RA). However, the 
article under evaluation shows an unexpected effect of RA – that of promoting a proinflammatory 
phenotype in intestinal DCs involved in the generation of inflammatory immune responses to 
dietary antigens. By using a double transgenic murine model that resembles human celiac 
disease, it was demonstrated that RA synergizes with IL-15 in promoting the breakdown of 
gluten tolerance and the development of enteropathy. The tissue microenvironment modulates 
DC function, and immune therapies that are based on RA aiming to restore oral tolerance should 
be used with caution because the presence of IL-15 (and/or other proinflammatory cytokines) 
may have undesirable effects.
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of Treg cells) disappear when neutralizing anti-IL-15 antibodies 
are used. The synergistic effect of IL-15 and RA in promoting a 
proinflammatory DC phenotype involved the activation of the 
JNK signaling pathway in a dose-dependent manner.
Focusing on the pathogenesis of celiac disease, a food protein 
intolerance characterized by the induction of a gluten-specific 
inflammatory Th1 response to dietary gluten [3], the authors tried 
to explain why up to 40% of the population carries the HLA-DQ2 
or HLA-DQ8 molecules associated with disease susceptibility, 
but only 2% of these develop a gluten-sensitive enteropathy. They 
hypothesized that the upregulation of IL-15 in the intestinal lam-
ina propria of celiac disease patients may be responsible for the 
breakdown of tolerance to gluten. Using double transgenic mice 
(by crossing IL‑15 transgenic mice with humanized HLA‑DQ8 
transgenic mice), they found that following gluten feeding, these 
mice developed features of early-stage celiac disease: gluten-
specific IFN-g-producing T cells, anti gliadin and anti-TG2 anti-
bodies, and intraepithelial lymphocytosis, but no villous atrophy. 
Moreover, the induction of inflammatory responses (Th1 cells and 
antigliadin antibodies) was dependent on and promoted by RA.
Discussion
The mucosal immune system is characterized by the negative 
regulation of the immune responses to dietary antigens and the 
commensal flora. The underlying mechanism, known as oral toler-
ance [4], depends on the properties of a unique population of muco-
sal CD103+ DCs with the ability to secrete TGF-b and RA, which 
promote the development of immunosuppressive Treg cells [5]. RA 
has little or no effect on its own, but acting synergistically with 
TGF-b1 promotes the induction of Treg cells at high  concentration, 
although at very low concentration Th17 cells are induced [6].
This article demonstrates that IL-15 promotes the production 
of the proinflammatory cytokines IL-12 and IL-23 by DCs, and 
reduces the ability of these cells to drive the generation of Tregs, 
at the same time that it induces Th1-type responses to dietary 
proteins. Moreover, RA should be considered not just a factor 
involved in oral tolerance as previously thought. Its effects depend 
on the intestinal microenvironment, and local factors would 
determine whether RA activates DCs towards a proinflammatory 
phenotype and the induction of immune responses against dietary 
antigens (by synergizing with IL-15 or IL-6, and the development 
of Th1 or Th17 cells, respectively), or the prevention of these 
responses (by cooperating with TGF-b in Treg cell differentia-
tion). This may be relevant for new immunomodulatory thera-
pies aiming to restore oral tolerance in intestinal inflammatory 
disorders and based on the use of RA. These strategies should 
be used with caution because, particularly in patients suffering 
inflammatory disorders, including those affecting the intestine, 
the outcome may be not what it is expected when IL-15 and/or 
other  proinflammatory cytokines are present.
The authors suggested that “there are no unconditional sup-
pressive factors, and that integration of tissue and exogenous sig-
nals determine the class of the immune response…”, and this is 
perhaps the relevant point: the ability of the tissue environment 
to modulate the phenotype and function of DCs may change 
depending on the context, with unwanted results. Future studies 
should aim to confirm these results in humans, identifying pos-
sible differences between intestinal DCs in humans and animal 
models, such as mice, as well as studying the effects of other fac-
tors or cytokines (e.g., IL-4 or -5) in the same context. Moreover, 
it would be very interesting to know how and how long these pro-
inflammatory DCs can be reprogrammed for, and, if the repro-
gramming process were to be performed ex vivo, how the in vivo 
conditions would affect the phenotype of these DCs.
Celiac disease is a chronic inflammatory intestinal disorder 
caused by an inappropriate immune response to dietary gluten 
proteins (prolamines) from cereals in genetically predisposed 
(HLA‑DQ2 or ‑DQ8) individuals [2]. The disease is the result of 
the breakdown of tolerance to gluten proteins and the induction 
of an inflammatory Th1 response characterized by high levels of 
IFN-g and other proinflammatory cytokines [3]. These gluten-
reactive CD4+ T cells from the intestinal lamina propria recognize 
gluten peptides modified by the enzyme tissue transglutaminase 
(TGt) in the context of HLA-DQ2 or -DQ8 molecules presented 
by local antigen-presenting cells (such as DCs). Moreover, gluten 
also induces the expression of IL-15 by enterocytes, mediating 
cytotoxicity against the intestinal  epithelium [7].
What this article demonstrates by using a double transgenic 
mouse model (the result of crossing humanized HLA‑DQ8 and 
IL‑15 transgenic mice), is that IL-15 and RA cooperate in the 
breakdown of tolerance to dietary gluten owing to the IL-15-
mediated production of proinflammatory cytokines by DCs, 
which leads to the induction of an aberrant inflammatory Th1 
response to gluten proteins. This may explain why only a small 
percentage of HLA‑DQ2/‑DQ8-positive individuals develop the 
gluten-associated enteropathy. Moreover, under inflammatory 
conditions (such as overexpression of IL-15, as occurs in celiac 
disease), RA acts as a co-adjuvant in the induction of the inflam-
matory T-cell-mediated response to gluten. The results also sup-
port the idea that IL-15 should be included as a target in any 
future therapeutic strategy for celiac disease and, perhaps, for 
other intestinal inflammatory disorders.
Finally, the authors proposed that the double transgenic 
HLA‑DQ8 and IL‑15 mice may be the long-awaited model for the 
study of the physiopathology of the early stages of celiac disease. 
No doubt this is an important step forward; however, the model 
does not reproduce the complete pathogenesis of celiac disease, 
but the early events of the disease perhaps related to the activa-
tion of the adaptive arm of the immune response to gluten pro-
teins. This should be taken into account when extrapolating the 
results. For example, the model is characterized by over expression 
of IL-15 in the lamina propria, but before epithelial damage and 
villous atrophy takes place, though intraepithelial lymphocytosis 
is observed. In human celiac disease, at least part of IL-15 syn-
thesis depends on the enterocytes under stress directly induced 
by gluten peptides becoming the target of cytotoxic mechanisms. 
Actually, the sensitivity to IL-15 in human celiac disease may be 
increased [8]. Another difference is related to IL-12 production: the 
correlation between IL-15 and IL-12 reported in the article is not 
strong enough (with just one case showing high IL-12 expression). 
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Moreover, it has been previously reported that IL-12 is absent from 
the intestine of celiac disease patients [3,9], and the relevance of 
the IL‑12A gene for celiac disease predisposition is not yet known. 
Five-year view
The article under evaluation is an important step forward in the 
direction of deciphering the mechanisms underlying oral toler-
ance to dietary proteins and the commensal flora, and it shakes 
some preconceived ideas, particularly regarding the role of RA 
and other local microenvironmental factors. There is a great need 
to clarify and understand these mechanisms, although this will 
take some time and does not seem to be round the corner yet. 
The article discussed is relevant to celiac disease, a model where 
the upregulation of IL-15 in the intestine, and the co-adjuvant 
effect of RA may lead to a breakdown of oral tolerance and the 
development of a gluten-related enteropathy. However, the results 
shown here have to be validated in humans. It is conceivable that 
an animal model with the ability of reproducing the complete 
physiopathology of celiac disease will be available in a few years. 
This (still) missing model will be very useful for the study of 
dietary protein-related disorders. An important task ahead is to 
find out how intestinal immune homeostasis is maintained, and 
how conditioning factors, such as RA in the context of cytokines, 
determine the acquisition of a tolerogenic or proinflammatory 
phenotype in DCs. Translating this knowledge to design immu-
nomodulatory strategies based on DC reprogramming will be a 
challenge. Finally, the study underlines the point that IL-15 should 
also be a target in future intestinal anti-inflammatory therapies.
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Key issues
• Intestinal immune responses to dietary proteins and commensal flora are strictly controlled, and dendritic cells (DCs) have a central role 
in this process. 
• By producing TGF-b and retinoic acid (RA), intestinal DCs drive the development of Treg cells.
• IL-15 reduces the ability of DCs to induce the generation of Treg cells and, unexpectedly, RA synergizes with IL-15 in reducing the 
number of Treg cells.
• In a double transgenic mouse model partially reproducing human celiac disease, IL-15 may be responsible for the breakdown of 
tolerance to dietary gluten.
• In this model, RA cooperates with IL-15 to induce DC-mediated production of proinflammatory cytokines (IL-12 and IL-23) and a Th1 
response to gluten.
• Therefore, RA is not only a mediator of tolerance (as previously thought), but in the presence of other cytokines may activate DCs 
towards a proinflammatory phenotype, and the induction of specific proinflammatory Th1 responses.
• These results should be confirmed in humans, and possible differences between mouse and human intestinal DCs taken into account.
• Future therapies aiming to restore tolerance should be used with caution, particularly in patients suffering inflammatory disorders. 
• These new anti-inflammatory strategies may include IL-15 as one of the targets through the use of neutralizing antibodies.
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